Showing results (51-60 of 10,487) with videos related to
Sort By:
Pageof 1,049
Journal of the Endocrine Society|July 3, 2024
Prevalence and Characteristics of Low-renin Hypertension in a Primary Care PopulationSonali S Shah, Renata Libianto, Stella May Gwini, et al.Hormones & Cancer|May 16, 2013
Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell linesStacey Jamieson, Peter J FullerCurrent Opinion in Oncology|December 25, 2008
Management of granulosa cell tumour of the ovaryStacey Jamieson, Peter J FullerEndocrine Reviews|January 14, 2012
Molecular pathogenesis of granulosa cell tumors of the ovaryStacey Jamieson, Peter J FullerJournal of Molecular Endocrinology|September 13, 2022
Regulation of mineralocorticoid receptor activation by circadian protein TIMELESSColin D Clyne, Kevin P Kusnadi, Alexander Cowcher, et al.Journal of Human Hypertension|May 12, 2026
Prevalence, clinical characteristics and management of low-renin hypertension: a real-world cohort studySonali S Shah, Chrislyn Ng, Minn Wei Chow, et al.Clinical Endocrinology|May 14, 2020
Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralizationNicholas Y N Chee, Azni Abdul-Wahab, Renata Libianto, et al.Journal of Human Hypertension|July 18, 2024
A Randomized trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER): rationale and study designSonali S Shah, Stella May Gwini, Michael Stowasser, et al.Molecular and Cellular Endocrinology|March 20, 2003
Interdomain interactions in the mineralocorticoid receptorFraser M Rogerson, Peter J FullerHypertension (Dallas, Tex. : 1979)|November 16, 2005
Mechanisms of mineralocorticoid actionPeter J Fuller, Morag J YoungPageof 1,049